Why this site says anti-wrinkle injections, and never the brand name

Read enough of this site and you will notice a tic. We write "anti-wrinkle injections" when talking to patients and "botulinum toxin" when talking clinically, and we never use the famous brand name. Readers occasionally assume it is squeamishness about trademarks, or some SEO superstition.

It is neither. In the UK, advertising that product to the public is against the rules, and has been for years. This article is the one place on the site where we use the word, because explaining the rule properly requires naming the thing the rule is about. If you are a patient it explains why every compliant clinic sounds oddly coy. If you run a clinic that markets to British customers, it is the summary of what you can and cannot say.

The short answer: it is a prescription-only medicine

Botox is a brand name for a botulinum toxin product, and botulinum toxin is a prescription-only medicine in the UK. That single fact drives everything else. The ASA's own guidance is unambiguous: botulinum toxin "is a prescription only medicine (POM) and as such, cannot be advertised to the public."

The relevant provision is rule 12.12 of the CAP Code, which prohibits advertising prescription-only medicines to the public. It is not a rule about aesthetics specifically. It is medicines law and advertising self-regulation working together, and it applies identically to a high street pharmacy and to a Harley Street clinic.

So the answer to "can you advertise Botox in the UK" is no, not to the public, not by that name, and not by an obvious nickname for it either.

What rule 12.12 actually stops you doing

The ASA's advice on botulinum toxin products, last updated in October 2025, is more specific than most clinics realise. The following are all out.

Naming it. You cannot use the word Botox or the brand names of other botulinum toxin products in advertising directed at consumers.

Hinting at it. Coinages such as "Beautox" are treated as indirect references to the product and are prohibited on the same basis. Splitting a service menu into "cosmetic injections" as a separate category from dermal fillers can still breach the rules if the promotion implies a prescription-only treatment.

Before and after photographs. The ASA's position is that these are "likely to be interpreted... as an efficacy claim, which is not permitted" for a prescription-only medicine.

Endorsements. Rule 12.18 prohibits using celebrities or health professionals to endorse prescription-only medicines.

Comparative claims. You cannot promote an alternative product by implying it achieves results comparable to Botox, because that references the prescription-only medicine.

Unlicensed uses. References to uses beyond the product's licensed indications are not permitted.

What survives is narrower than most clinic websites assume. Marketers offering injected treatments that are not prescription-only medicines may describe them as "cosmetic fillers" or "injected fillers" without invoking the brand. And a clinic or pharmacy website may refer to a prescription-only medicine in the context of it being a possible treatment option following a consultation, which is the carve-out that allows a proper patient information page to exist at all. That is a much smaller door than "put it on the price list".

Under-18s: the 2021 Act

Separately from advertising, there is a criminal offence. The Botulinum Toxin and Cosmetic Fillers (Children) Act 2021 came into force on 1 October 2021. Section 1 makes it an offence to administer, in England, botulinum toxin or a subcutaneous, submucous or intradermal injection of a filler for a cosmetic purpose to a person under 18.

The defences are tightly drawn: that the defendant was a registered medical practitioner, that they were a regulated health professional acting in accordance with the directions of a registered medical practitioner, or that they had taken reasonable steps to establish the person's age and reasonably believed them to be 18 or over. Conviction is on summary conviction to a fine.

The Act defines "filler" broadly as any substance used for dermal or mucous membrane filling, whether or not designed for that use, and treats an injection as cosmetic if the filler is generally used that way or if the likely effect is to alter the person's appearance. There is no wriggle room in the drafting.

What is coming, and what has not arrived

The bigger structural change in the UK has been promised for some time and is still not in force.

Section 180 of the Health and Care Act 2022 gives the government the power to establish a licensing scheme for non-surgical cosmetic procedures in England and Wales. The government consulted in autumn 2023 and published its response on 7 August 2025, proposing a three-tier, risk-based model: green for the lowest-risk procedures, amber where non-healthcare practitioners would need a licence with oversight from a regulated healthcare professional, and red for the highest-risk procedures, restricted to qualified regulated healthcare professionals and brought within Care Quality Commission regulation. The response said the government would "prioritise initial work in this space on the introduction of legislation which will ensure that those procedures deemed to pose the highest level of risk (including procedures aimed at augmenting the breast, buttocks and genitals with dermal fillers) can only be performed by suitably qualified regulated healthcare professionals."

In December 2025 ministers told Parliament that a consultation on restricting those highest-risk procedures was planned for spring 2026. In February 2026 the Women and Equalities Committee reported that the government "should accelerate regulatory action", that high-risk procedures such as liquid BBLs "should be restricted to appropriately qualified medical professionals immediately", and that a licensing system for green and amber procedures "should be introduced within this Parliament". The committee also recommended systematic recording of complications arising from procedures performed abroad, and bringing UK outlets that recruit patients for overseas treatment into a regulatory regime.

As of September 2026, none of that has taken effect. The House of Commons Library briefing on the subject, last updated on 8 July 2026, records no specific implementation timeline beyond the 2025 announcements, and the government's consultation page still shows the August 2025 response as its latest formal position. Anyone telling you the licensing scheme is already in force is mistaken.

What to say instead

The practical vocabulary, for clinics and for patients:

This is why our anti-wrinkle injections treatment page reads the way it does, and why compliant clinics in our aesthetic medicine directory use the same language. It is not a house style. It is the only way to write about this lawfully for a British audience.

Does this apply to a Spanish clinic advertising to Britons?

Partly, and the distinction is worth knowing.

The ASA's country of origin guidance says that for ads in paid-for space, "the deciding factor is whether the ad targets consumers in the UK". A Spanish clinic buying paid advertising aimed at British customers is therefore within scope, wherever the clinic sits. Non-paid content from a non-UK advertiser, an organic social post or the clinic's own website, generally falls outside the ASA's direct remit, though the ASA can refer complaints to the equivalent body in the advertiser's country through the European Advertising Standards Alliance cross-border system.

The commercial reality matters more than the jurisdictional one. A paid campaign naming the product to a UK audience risks an ASA ruling and the platform enforcement that follows. Clinics that want a listing with us are asked to use compliant language for the same reason: it is the only language that works across both markets.

What this means if you are the patient

Two things, both useful.

Coy wording is a compliance signal, not a warning sign. A clinic writing "anti-wrinkle injections" is usually the one paying attention to the rules. The clinic splashing the brand name across a discount graphic is advertising a prescription-only medicine to the public, which tells you something about its attitude to the rest of the rulebook.

And the underlying point holds on both sides of the Channel. This is a prescription medicine that requires a prescriber who has assessed you. It is the reason injectables belong in a licensed clinic rather than a salon, which is exactly the line our guide to checking a Spanish clinic's registration helps you draw, and the reason enforcement cases in Spain have concentrated on premises outside the health system, as we set out in our safety guide. Our verification method checks the licence before anything else.

Frequently asked questions

Related guides

Your rights

If a cosmetic procedure goes wrong in Spain: a practical route map

A calm, practical route map: which documents to gather, the complaint forms to use, who to complain to in what order, time limits, and help from abroad.

Your rights

The money games, and what Spanish law actually says about them

Eight money tactics used in aesthetic clinics, what Spanish consumer law says about each, and the sentence that ends most of them.

Choosing a clinic

Fourteen red flags, and how to check each one before you pay

Fourteen things a clinic does before it hurts you. Each one is checkable in minutes, from your phone, before you hand over a deposit.